Helmut Zodl - Jan 4, 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
Chief Financial Officer
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
Jan 4, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 07:39 PM
Previous filing
Dec 14, 2022
Next filing
Feb 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Restricted Stock Units Award +11.9K 11.9K Jan 4, 2023 Common stock, par value $0.01 per share 11.9K Direct F1, F2
transaction GEHC Restricted Stock Units Award +17.4K 17.4K Jan 4, 2023 Common stock, par value $0.01 per share 17.4K Direct F1, F3
transaction GEHC Restricted Stock Units Award +1.99K 1.99K Jan 4, 2023 Common stock, par value $0.01 per share 1.99K Direct F1, F4
transaction GEHC Restricted Stock Units Award +11.7K 11.7K Jan 4, 2023 Common stock, par value $0.01 per share 11.7K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, at settlement, one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare").
F2 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.
F3 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024.
F4 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on June 1, 2023 and 50% will vest on June 1, 2024.
F5 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.